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Brain-type creatine kinase B-CK (EC 2.7.3.2) was purified from several chicken tissues, e.g. cardiac muscle, brain, gizzard and retina. Two major 
monomeric chicken B-CK subunits, designated Bb (basic) and Ba (acidic}, which differ in isoel&ric point, were separated by chromatofocussing 
in the presence of 8 M urea on a MonoP column. The two subunits were shown by peptide mapping, amino acid analysis and partial sequencing, 
as well as by irnrn~olo~~l criteria, to be distinct B-CK polypeptides. The N-terminal sequence of 30 amino acid residues of Bb correspond entirely 
to data derived from a B-CK c-DNA clone termed H4 j(I986) Nucleic’ Acids Res. 14, 1449-14631, whereas the N-terminus of the acidic Ba species 
was blocked. Native dimeric B-CK isoenxymes obtained from these tissues were separated by ion exchange chromatography on a MonoQ column 
yielding two B-CK dimer populations, type-1 and type-II B-CK, varying in relative proportions. Quantitation of the CK activity peak ratios of 
these two populations revealed the existence of a tissue-specific, post-translational mechanism regulating B-CK dimerixation in neural tissues. 
Tissue-specific dimerization of the two distinct B-CK monomer species may represent a means of specifying the intracellular distribution of the 
dimeric B-CR subspecies. 
Creatine kinase isoenzyme; Heterogeneity of brain-type creatine kinase; Tissue-specific dimerization of B-CK; Subcellular compartmentation 
1, INTRODUCTION 
Proteins often exist in tissue- or even cell compart- 
ment-specific isoforms. While essentially fulfilling the 
same structural and/or catalytic role, these isoenzymes 
differ in order to respond more efficiently to the spe- 
cialized metabolic requirements of their local environ- 
ments. Isoenzymes, therefore, endow an organism with 
greater metabolic flexibility and precision. In syn- 
thesizing isoenzymes, organisms have exploited several 
different mechanisms [I]. The simplest employ dif- 
ferent genes to encode proteins which can differ in a 
number of aspects, but display the same basic catalytic 
activity. Creatine kinase (CK) is an example of such a 
multilocus enzyme [2]. 
Creatine kinase plays a critical role in the energy 
metabolism of tissues or of cellular systems with sudden 
changes in energy requirements, such as skeletal and 
cardiac muscle, brain, photoreceptor cells and sper- 
matozoa (for review, see [3]). Most higher vertebrates 
express two ‘cytosolic’ CK isoforms, brain-type B-CK 
and muscle-type M-CK. Active, dimeric cytosolic 
isoforms are expressed in a tissue-specific manner [4]. 
In chicken, the more ubiquitous B-CK is present in 
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adult brain, smooth muscle, heart and several other 
tissues as well as in embryonic cells 151. M-CK is ac- 
cumulated in adult chicken skeletal muscle [6], but con- 
trary to mammalian heart where both M- and B-CK are 
expressed to yield significant amounts of MB- 
heterodimers, only B-CK is found in chicken cardiac 
muscle [7]. A third type of CK isoe~ymes, mitochon- 
drial creatine kinases (MCCK), strictly confined to the 
mitochondria, are co-expressed with B- or M-CK [8]. 
Compartmentalization of CK isoenzymes, however, 
is not restricted to the mitochondrial isoform, Cytosolic 
isoenzymes are associated with distinct structural and 
functional subcellular components where ATP is 
generally consumed 131. For instance, M-CK is 
associated with the M-line of skeletal and cardiac mus- 
cle [9], where it is functionally coupled to the 
myofibrillar actin-activated Mg-ATPase [IO]. This 
association is isoenzyme-specific, since only MM-CK, 
but neither MB- or B-CK, bind to the M-band of 
myofibrils [ 11,121. Although targets with which B-CK 
might be functionally coupled have not been identified, 
B-CK has been found in association with synaptic 
vesicles [13,14] and with post-synaptic membranes of 
Torpedo electrolytes [13,15,16]. 
Apart from the tissue-specific B- and M-CK iso- 
forms, additional B-CK subspecies with slightly dif- 
ferent isoelectric points have been detected within the 
B-CK isoform itself from birds [17]. It was shown that 
purified chicken B-CK gives rise to two main protein 
spots on two-dimensional gels [S]. These two major B- 
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CK subunit species, which now have been termed Bb 
and Ba are present in approximately equal amounts in 
several chicken tissues (brain, heart, gizzard) [5]. A 
similar 1: 1 B-CK monomer ratio was obtained by in 
vitro translation of poly A+ mRNA, both by a cell-free 
system and in frog oocytes [5,12,18]. So far these B-CK 
subspecies have evaded further characterization. 
Here we report on the isolation and characterization 
of the two monomer species by chromatofocussing in 
the presence of urea and present data showing that Ba 
and Bb are similar, but distinct protein species which 
dimerize in a tissue-specific fashion. A possible role of 
this mechanism in determining the subcellular distribu- 
tion of B-CK isoenzymes is discussed. 
2. MATERIALS AND METHODS 
2.1. Preparation of native brain-type creatine kinase 
All reagents used were of analytical grade quality. Enzyme purifica- 
tion steps were performed at 4”C, unless stated otherwise. Native B- 
CK dimer populations were prepared as described [19]. In short, 
chicken tissues were homogenized and extracted in MSH buffer (220 
mM mannitol, 70 mM sucrose, 10 mM Hepes, 1 mM EGTA, 5 mM 
MgClz, 2 mM,&mercaptoethanol (bME), at pH 7.4). The 13 000 x g 
supernatant was subsequently fractionated by a 50% (at pH 7.0) to 
65% (at pH 6.2) ammonium sulfate cut, dialyzed against BS 7.0 buf- 
fer (20 mM sodium phosphate, 1 mM EGTA, 5 mM MgC12, 2 mM 
bME at pH 7.0), adjusted to pH 6.3 and loaded onto a Sepharose blue 
column (Pharmacia, Sweden) equilibrated in BS buffer at pH 6.3. B- 
CK was preferentially eluted by BS 6.3 buffer containing 5-10 mM 
ADP. Fractions containing B-CK activity at 70% purity were pooled 
(BS pool) and precipitated by 80% ammonium sulfate at pH 6.2. 
After dialysis against BT 6.8 buffer (18 mM-Tris, 0.2 mM EGTA, 
1 mM MgClz, 2 mM bME at pH 6.8), samples were separated on an 
FPLC MonoQ HR 5/5 anion exchange column (Pharmacia). 
2.2. Preparation of Ba and Bb monomers 
Chicken brain-type B-CK monomers Ba and Bb were separated by 
chromatofocussing of BS pool material on an FPLC MonoP HR 5120 
column in the presence of 8 M urea at room temperature. Per run on 
the MonoP column, equilibrated in BT buffer containing 8 M urea at 
a flow rate of 0.5 ml/min, 2 mg of protein were separated. B-CK was 
eluted in a pH gradient generated on the MonoP column by changing 
to PB-5.0 buffer (10% v/v of Polybuffer 74 (Pharmacia), 4 mM 
MgC12, 10 mM bME and 8 M urea at pH 5.0). 
2.3. Creatine kinase assay 
Creatine kinase activity measured by pH-stat assay [lo] was ex- 
pressed in IU (one international unit corresponding to 1 /mole of CP 
per minute at pH 7.0 and 25°C). 
2.4. SDS polyacrylamide gel electrophoresis and immunoblotting 
2D-gel analysis of B-CK samples was performed as previously 
described [19]. Proteins separated by SDS-PAGE [20] were first stain- 
ed with Coomassie blue (CB) and, if necessary, by subsequent silver- 
staining [21]. 2D-gels were either CB-stained or electroblotted onto 
nitrocellulose [22]. After reversible staining for protein with Ponceau 
red-S dye, the blots were immuno-stained with goat anti-chicken B- 
CK antibodies at 1: 50 to 1: 250 dilution followed by horseradish 
peroxidase-conjugated second antibody (Cappel, Dynatech Prod. 
Zurich) at 1: 2000 dilution and vizualized by peroxidase staining using 
4-chloro-1-naphthol as a substrate. 
2.5. Antibody preparation and affinity purification 
Polyclonal antibodies against purified B-CK (type-II) were raised in 
300 
goats. The animals received 3 initial immunizations: day 1, 1.5 mg in 
complete Freund’s adjuvant; day 20, 1.5 mg in a mixture of complete 
and incomplete adjuvant; and day 35, 1.5 mg in incomplete adjuvant. 
Antisera, isolated from blood obtained 20-30 days after the third im- 
munization, reacted specifically on immunoblots with B-CK, present 
in different tissue extracts separated by SDS-PAGE. 
Anti-B-CK antibodies were cross-adsorbed by passing 0.2-0.5 ml 
aliquots of anti-B-CK serum through a type-1 B-CK affinity column, 
prepared by covalently coupling 3 mg of the B-CK subspecies to 
CNBr-activated Sepharose (Pharmacia). Bound IgG enriched in an- 
tibodies specific for the basic Bb B-CK subunit species was eluted by 
1 M propionic acid at pH 2.3 followed by immediate neutralization 
with Tris base. 
2.6. Protein characterization by partial digestion 
B-CK subunits were characterized by partial proteolytic or chemical 
fragmentation followed by peptide mapping on 5-15% poly- 
acrylamide gradient gels. Purified Ba and Bb monomers were in- 
dividually digested by thermolysin (Sigma) in 0.1 M ammonium car- 
bonate, 6 mM CaClz, 0.2% SDS at 56°C; by trypsin (Sigma) in 0.15 
M sodium phosphate, 0.1% SDS, pH 7.2 at room temperature; by V8 
protease (Boehringer Mannheim) in 0.125 M sodium phosphate; 
0.1% SDS, pH 7.0 at 37°C; or by cyanogen bromide in 50% formic 
acid at room temperature. 
2.1. Quantitative amino acid analysis 
Quantitative amino acid analysis, kindly performed by Mrs M. 
Wirth, ETH Zurich, was done on a Biotronic LC 6000 E analyser us- 
ing a Mitsubishi CK 10s ion exchange column [23]. For the quantita- 
tion of serine and threonine a time course of acid hydrolysis from 12 
to 120 h was chosen and the respective amino acids quantitated at 
each time point. 
2.8. N-terminal amino acid analysis 
Amino acid sequencing was done on an Applied Biosystems 470A 
gas/liquid-phase microsequenator by Dr P. Bohlen and later by direct 
sequencing of the individual B-CK spots after separation by elec- 
trophoresis on two-dimensional gels and electroblotting of the spots 
onto glass-fibre filters by Dr J. Vanderkerckove [24]. 
3. RESULTS 
3.1. Monomer separation 
In order to characterize the subunits present in B-CK 
dimers, the monomers were separated by chromato- 
focussing on an FPLC MonoP column. The purity of 
B-CK peak fractions obtained by separation on the 
MonoP column (not shown) was comparable to that of 
B-CK isolated on the MonoQ column [19]. A typical 
MonoP profile of B-CK is shown in fig.lA and the B- 
CK monomer composition of the corresponding 
MonoP fractions is shown after 2D-gel analysis in 
fig. 1B. The peak ratios of the two major B-CK subunit 
species is 1: 1 (compare peak size of fractions (a) and (c) 
of fig. 1A). An additional minor B-CK subunit species, 
Bb*, was apparent in intermediate fractions ((b) of 
fig. 1A). 
3.2. Characterization of Ba and Bb monomers of B-CK 
Isolated Ba and Bb monomers were characterized in 
several different ways as summarized in table 1. The 
monomers had identical MI values, but differed in their 
isoelectric points and, as suspected, eluted from a 
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Fig. 1. Separation of B-CK subunits Ba and Bb by chromatofocussing and characterization on ZD-gels. (A) Material eluted from Blue Sepharose 
affinity chromatography was further purified by chromatofocussing on a MonoP HR 5/20 column (Pharmacia) in the presence of 8 M urea. The 
pH of the eluted fractions is indicated by a dashed line and the recorder tracing of absorbance at 270 nm by a solid line. Two peaks of equal size 
were resolved corresponding to the individual B-CK monomers Bb and Ba which were eluted at pH 5.7 and pH 5.6, respectively. Fractions (0.5 
ml each) indicated by the shaded areas (a, b and c) were analyzed on 2D-gels. (B) Approximately 3 pg of protein from MonoP fractions (a, b and 
c) were separated on ZD-gels and stained with Coomassie blue. In the initial peak only basic Bb monomers (a) were seen, while the second peak 
contained exclusively acidic Ba monomers. (c) Intermediate fractions contained a yet unidentified species, called Bb*, in addition to Bb monomers 
(b). 
chromatofocussing column at different pH values. The 
overall amino acid composition was nearly identical ex- 
cept for serine, where a difference of 3 residues was 
found. Deviations in values determined for other amino 
acid residues were within the 5% error range. For exam- 
ple, the threonine content, analyzed by the same time 
course procedure as used for serine, was found to be 
identical (18 residues) for both monomers. 
Table 1 
Summary of comparison between Ba and Bb monomers showing the 
two monomers to be similar proteins, but with distinct amino terminal 
regions 
Characterization Monomer Ba Monomer Bb 
M, (SDS-PAGE) identical (43 kDa) 
IEP (ZD-gels) 6.1 6.5* 
Eluent pH (MonoP, fig. 1A) 5.6 5.7 
Serine residues per 380 amino acids 18 21 
Partial cleavage of polypeptides some peptide fragments 
(fig.ZB) (trypsin, BrCN) of Bb migrate 
with lower M, than those of 
Ba 
N-terminal amino acid analysis blocked identical to 
N-terminus H4 B-CK 
cDNA se- 
quence** 
N-terminal sequence of two inter- identical 
nal peptides at position 90 and 
120 
Immunoreactivity with polyclonal Yes No 
anti-B-CK, cross-absorbed on 
type-1 B-CK (fig.ZA) 
* See [5] 
** See [25] 
While partial cleavage of Ba and Bb with thermolysin 
and V8 protease gave identical peptide patterns (fig.2B; 
V8 digest not shown), a few of the peptides obtained by 
digestion of Bb-CK with trypsin and BrCN had slightly 
lower apparent A& values (fig.2B, lanes 2 and 6, ar- 
rowheads) compared to those of the corresponding 
cleavage products of Ba-CK (fig.ZB, lanes 1 and 5). N- 
terminal amino acid sequence analysis of Bb versus Ba 
revealed a difference at this end (table 1). Sequence data 
obtained for the first 30 amino acids of Bb-CK agreed 
precisely with cDNA-derived sequence data of the B- 
CK cDNA clone H4 [25], except that the N-terminal 
methionine encoded by this mRNA was no longer pres- 
ent in the mature protein. However, Ba-CK isolated 
and analyzed under the same conditions was blocked at 
the N-terminus showing that the N-termini of the two 
B-CK subunits, Ba and Bb, were indeed different. 
If the N-terminally blocked Ba species was subjected 
to chemical cleavage by 70% formic acid (at 40°C for 
24-28 h) at specific sites where an aspartic acid residue 
is followed by a proline, two fragments with readable 
N-termini were obtained. With the exception of two 
uncertainties indicated by X, the two internal amino 
acid sequences obtained, DPVIEDXHGG and 
DPNYVLSSRVXT, were in complete agreement with 
the amino acid sequence following the Asp(D)/Pro(P) 
sites at positions 90 and 120 predicted from the H4 B- 
CK cDNA. Thus, despite differences at the N-terminus 
the two monomer species were found to have identical 
sequences at two internal sites accessible to analysis, 
which is consistent with the similarity of the peptide 
patterns found between Ba and Bb B-CK monomer 
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Fig.2. Ba and Bb monomers are similar, but distinct proteins. (A) Dif- 
ferential immunoreactivity of Ba and Bb B-CK subunit species with 
cross-adsorbed anti-B-CK antibodies. Areas of interest from parallel 
ZD-gels with purified chicken B-CK after electrophoretic transfer on- 
to nitrocellulose membranes are shown. The two B-CK subunit 
species, Ba and Bb, as well as the modified Bb species termed Bb*, are 
present, as revealed after staining for protein by Ponceau red-S (panel 
a); and after immunostaining with polyclonal goat anti-chicken B-CK 
antiserum at 1:250 dilution (panel b). The anti-B-CK serum 
recognizes both B-CK spots with equal intensity. Immunostaining 
with pooled breakthrough fractions (at 1: 50 dilution) of the same 
serum, but after adsorption on a type-1 B-CK affinity column shows 
that the cross-adsorbed antibody specifically labels the acidic Ba spot 
(panel c), demonstrating partial immunological divergence of the two 
B-CK monomers. Antibodies eluted from the Bb-CK affinity column 
by propionic acid at pH 2.3 and subsequently diluted 1: 250 recognize 
both spots, indicating the presence of common epitopes on Bb and Ba 
(d). (B) Comparison of peptide fragments of Ba and Bb B-CK subunit 
types on silver-stained 5-15% gradient polyacrylamide SDS gels. 
Parallel samples of separated Ba (lanes 1, 3, 5) and Bb (lanes 2, 4,6) 
B-CK subunits digested under identical conditions are shown in pairs 
after cleavage by CNBr for 10 min (lanes 1,2); by thermolysin for 10 
min (lanes 3,4); and by trypsin for 10 min (lanes 5,6). Arrowheads in- 
dicate slight differences between Ba and Bb B-CK subunit-types in 
electrophoretic mobility of the corresponding peptides visible after 
digestion with CNBr (lanes 1, 2) and trypsin (lanes 5, 6). 
subspecies. Polyclonal goat anti-chicken B-CK an- 
tiserum was cross-adsorbed on a type-1 B-CK affinity 
matrix (fig.2A), on which only Bb monomers or 
derivatives thereof were present (fig.3, panel C(b)). An- 
tiserum flowthrough fractions from this column 
specifically recognized Ba monomers (fig.aA(c)). On 
the other hand, antibodies recovered by elution from 
the matrix with propionic acid recognized both Ba and 
Bb monomers (fig.2A(d)). This clearly illustrates that 
the two monomers have both similar as well as 
divergent immunological epitopes. 
3.3. Tissue-specific dimerization 
A comparison of MonoQ elution profiles between 
cardiac and brain B-CK (fig.3A,B) or gizzard and retina 
B-CK (table 2), revealed striking tissue-specific dif- 
ferences in the type-1 to type-II peak ratios. While B-CK 
purified from heart and gizzard both showed a peak 
ratio of approximately 1: 3, this ratio was about 1: 10 
for B-CK derived from brain and retina. The dif- 
ferences were entirely tissue-specific (table 2) and did 
not depend on the extraction conditions (salt, 
detergent, etc., not shown). The specific activity was 
constant throughout both peaks. For all tissues a B-CK 
monomer ratio of 1: 1 was seen on 2D-gels at all steps 
during purification before separation on MonoQ. A 
representative xample from brain tissue is shown in 
fig.3, panel C(a). While type-1 peaks contained B-CK 
dimers exclusively composed of Bb and Bb*, the latter 
most likely representing derivatives of Bb [26] (fig.3, 
panel C(b)), both Ba- and Bb-containing B-CK dimers 
were present in type-II peak fractions (fig.3, panel 
C(c)). The same 1: 1 monomer ratio as described above 
was obtained by chromatofocussing of partially 
purified enzyme on MonoP (fig.lA). 
4. DISCUSSION 
While having identical apparent M, values, B-CK 
monomers Ba and Bb are easily distinguished on 2D- 
gels. The two monomers have pZ values of 6.1 and 6.5, 
respectively (table 1). This pZ difference is too large to 
be explained on the basis of a simple post-translational 
modification; e.g. the addition of one phosphate group 
would result in a pZ change of 0.05-0.1 units in the 
acidic direction. On the other hand, the observed pldif- 
ference between Bb and Bb* could easily be explained 
by such a modification, i.e. Bb* representing modified 
Bb. Evidence supporting this interpretation is provided 
elsewhere [26]. 
In vitro translation of crude poly A+ mRNA from 
different B-CK-containing chicken tissues always yield- 
ed both major species in a 1: 1 ratio [5,12], supporting 
the concept that Ba and Bb are different proteins. Since 
CK dimers are extremely stable and can only be 
dissociated into monomers under denaturing conditions 
[4], Ba and Bb were separated from one another by 
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Fig.3. Two B-CK peaks (type-1 and -II) obtained by MonoQ chromatography show distinct monomer composition. (A) Elution profile of chicken 
cardiac muscle B-CK activity (IU/mg, shaded area) and protein (solid line) eluted by a salt gradient (dashed line) from a Pharmacia FPLC MonoQ 
HR S/S column. Two B-CK peaks were eluted by an isocratic step at 150 mM NaCl. The length of the bar in the upper left hand corner represents 
1 ml elution volume. For optimal resolution the fraction size was varied. (B) This panel shows a representative elution profile of brain B-CK on 
the MonoQ column. Figure specifications are the same as in panel A. (C) Characterization of monomer species present in individual brain B-CK 
peaks by 2D-gel electrophoresis. Panel (a) shows 3-5 pg of CB-stained B-CK protein, while in panel (b) and (c) 1 pg of silver-stained protein are 
shown. Separation in the first direction by isoelectric focussing between pH 5 and 8, indicated along the horizontal axis, was followed by separation 
according to M, on SDS-PAGE. Material from the Blue Sepharose column, highly enriched in B-CK is shown in panel (a). The ratio of Ba: Bb 
species was still close to 1: 1. Additionally, a species termed Bb* was often resolved. Type-I B-CK peak fractions fb) contained only B-CK dimers 
composed of Bb or Bb*. In contrast, type-11 B-CK peak fractions (c) contained dimers composed of both major monomers Ba and Bb. 
Table 2 
Tissue-specific dimerization of Ba and Bb monomers 
Chicken-tissue xtract MonoQ type-1 to type-II peak 
ratios 
Heart 1:3-4 (fig.3A) 
Gizzard 1:3-4 (see WI) 
Brain 1:9-10 (fig.SB) 
Retina 1:9-10 (see U91) 
B-CK activity ratios clearly differ in a tissue-specific manner. While 
in muscle-like tissues (heart, gizzard) the type-1 to type-II B-CK peak 
ratio reflects random association of Ba and Bb monomers, neuronal 
tissues differ in this respect (see section 4). In all cases studied, both 
monomers were present in a 1: 1 ratio in the B-CK pool fractionated 
on the MonoQ column. The specific B-CK activity in both peaks was 
identical 
chromatofocussing in the presence of 8 M urea. Subse- 
quent protein characterization revealed that the in- 
dividual B-CK monomers are indeed similar (two iden- 
tical internal peptide sequences, identical overall amino 
acid composition (except for serine) and digest patterns 
with thermolysin and V8 protease), but distinct proteins 
(different serine content, different N-termini, differen- 
tial immuno-reactivity with polyclonal antibodies) 
which are encoded by different mRNAs [28]. 
Together with the information obtained by com- 
parison of the total amino acid composition, the pro- 
teolytic cleavage pattern and the immunological cross- 
reactivity of the two B-CK subunit species, Ba and Bb 
(summarized in table I), the complete correspondence 
of more than 20 internal amino acid residues equenced 
at two different sites is direct proof that Ba is indeed a 
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B-CK polypeptide highly homologous to Bb, but with a 
different N-terminus. Due to N-terminal blockage of 
the Ba monomer, no direct comparison of the N- 
terminal amino acid sequences could be made. It is im- 
portant to note that as far as the total amino acid com- 
position is concerned, the serine content was the only 
significant difference between Bb and Ba, with Ba con- 
taining at least 3 serine residues less than Bb (table 1). 
Such a difference in serine content, ~though totalling a 
number of 4, corresponds to the cDNA-derived N- 
terminal amino acid sequence difference between the 
cDNA clone H4, coding for Bb, and a recent cDNA 
clone 18c, most likely coding for the Ba subunit [27]. 
Ba and Bb were shown to dimerize in a tissue-specific 
fashion. In all cases the monomer ratio was 1: 1 prior to 
separation of the dimer species, ruling out the possibili- 
ty that selective loss of distinct enzyme sub-populations 
may account for the difference in type-1 to -11 B-CK 
peak ratios obtained on the MonoQ column. No devia- 
tions were obtained even when extraction conditions 
varied considerably. Since CK dimers do not dissociate 
under native conditions 141, the probability that an 
equilibrium between B-CK dimer species might com- 
plicate the interpretation of these experiments can be 
excluded, The type-1 to type-II cardiac and gizzard B- 
CK peak ratio corresponds to what would be expected 
by random association of Ba and Bb monomers present 
at a 1: 1 stoichiometry, The peak ratio observed for 
neural tissues, like brain and retina, cannot be explain- 
ed on this basis, but rather indicates that in these tissues 
a mechanism ensures the almost exclusive pairing of Ba 
with Bb monomers to form preferentially heterodimeric 
B-CK molecules. 
This is the first time to our knowledge that such a 
mechanism has been described for creatine kinase. In 
general, it is assumed that oligomerization of multi- 
merit isoenzymes is a random association process [2]. 
Post-translational modulation of oligomeric isozyme 
composition, however, could possibly lead to more 
precise subcellular targeting of the enzyme. Since dif- 
ferent CK isoenzymes generally appear to be associated 
with distinct subcellular compartments [3], it is sug- 
gested that tissue-specific dimerization of B-CK 
monomers might represent a mech~sm for specifying 
the intracellular distribution of this cytosolic isoform. 
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